Ian Mongrain

678 total citations
25 papers, 305 citations indexed

About

Ian Mongrain is a scholar working on Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ian Mongrain has authored 25 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ian Mongrain's work include Pharmacogenetics and Drug Metabolism (10 papers), Genetic Associations and Epidemiology (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ian Mongrain is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Genetic Associations and Epidemiology (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ian Mongrain collaborates with scholars based in Canada, United States and United Kingdom. Ian Mongrain's co-authors include Marie‐Pierre Dubé, Sylvie Provost, Yassamin Feroz Zada, Jean‐Claude Tardif, Simon de Denus, Bjoern Peters, Michael Phillips, Eric W. Deutsch, Kevin A. Kovalchik and Alessandro Sette and has published in prestigious journals such as Circulation, Molecular & Cellular Proteomics and Human Genetics.

In The Last Decade

Ian Mongrain

23 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Mongrain Canada 10 101 72 69 66 54 25 305
Carmen M. Dumaual United States 9 116 1.1× 70 1.0× 109 1.6× 111 1.7× 30 0.6× 9 368
Cristina Lucía Dávila-Fajardo Spain 13 94 0.9× 38 0.5× 99 1.4× 77 1.2× 48 0.9× 24 367
Guangyan Mu China 11 75 0.7× 99 1.4× 143 2.1× 52 0.8× 20 0.4× 52 383
Rhonda Porche-Sorbet United States 12 89 0.9× 73 1.0× 63 0.9× 199 3.0× 56 1.0× 16 528
Jing‐Min Zheng China 9 75 0.7× 37 0.5× 40 0.6× 64 1.0× 71 1.3× 14 390
Michael W. Bolt United States 9 162 1.6× 47 0.7× 46 0.7× 30 0.5× 67 1.2× 16 419
Mu-Peng Li China 11 92 0.9× 47 0.7× 112 1.6× 25 0.4× 45 0.8× 27 332
Tester F. Ashavaid India 12 122 1.2× 83 1.2× 40 0.6× 27 0.4× 20 0.4× 35 335
Liuh Ling Goh Singapore 11 80 0.8× 29 0.4× 35 0.5× 43 0.7× 25 0.5× 28 299
Mohammed Tarif Hamza Egypt 9 116 1.1× 39 0.5× 27 0.4× 68 1.0× 34 0.6× 19 342

Countries citing papers authored by Ian Mongrain

Since Specialization
Citations

This map shows the geographic impact of Ian Mongrain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Mongrain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Mongrain more than expected).

Fields of papers citing papers by Ian Mongrain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Mongrain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Mongrain. The network helps show where Ian Mongrain may publish in the future.

Co-authorship network of co-authors of Ian Mongrain

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Mongrain. A scholar is included among the top collaborators of Ian Mongrain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Mongrain. Ian Mongrain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jutras, Martin, Ian Mongrain, Caroline Lagacé, et al.. (2024). A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress. European Journal of Clinical Pharmacology. 81(2). 321–332.
2.
Gagnon, Daniel, Hadiatou Barry, Amina Barhdadi, et al.. (2023). A dataset of proteomic changes during human heat stress and heat acclimation. Scientific Data. 10(1). 877–877. 2 indexed citations
3.
Leclair, Grégoire, Martin Jutras, Ian Mongrain, et al.. (2023). Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males. Clinical and Translational Science. 16(5). 872–885. 1 indexed citations
4.
Provost, Sylvie, Grégoire Leclair, Martin Jutras, et al.. (2023). Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study. Pharmacogenomics. 24(8). 441–448. 1 indexed citations
5.
Dubé, Marie‐Pierre, Olympe Chazara, Audrey Lemaçon, et al.. (2022). Pharmacogenomic Study of Heart Failure and Candesartan Response from the CHARM Programme. ESC Heart Failure. 9(5). 2997–3008. 5 indexed citations
6.
Leclair, Grégoire, Martin Jutras, Ian Mongrain, et al.. (2022). An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites. Clinical and Translational Science. 15(8). 2024–2034. 12 indexed citations
7.
Lemaçon, Audrey, Géraldine Asselin, Sylvie Provost, et al.. (2021). Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women. The Pharmacogenomics Journal. 21(4). 446–457. 3 indexed citations
8.
Denus, Simon de, Sandra Korol, Yassamin Feroz Zada, et al.. (2020). A Genetic Association Study of Heart Failure: More Evidence for the Role of BAG3 in Idiopathic Dilated Cardiomyopathy. ESC Heart Failure. 7(6). 4384–4389. 10 indexed citations
9.
Vizcaíno, Juan Antonio, Peter Kubiniok, Kevin A. Kovalchik, et al.. (2019). The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases. Molecular & Cellular Proteomics. 19(1). 31–49. 67 indexed citations
10.
Shahabi, Payman, Yassamin Feroz Zada, Sylvie Provost, et al.. (2018). Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort. The Pharmacogenomics Journal. 19(2). 147–156. 6 indexed citations
11.
Perreault, Louis‐Philippe Lemieux, et al.. (2018). Pharmacogenetic Content of Commercial Genome-Wide Genotyping Arrays. Pharmacogenomics. 19(15). 1159–1167. 8 indexed citations
12.
Denus, Simon de, Jean-Lucien Rouleau, Douglas L. Mann, et al.. (2017). CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. The Pharmacogenomics Journal. 18(2). 232–237. 11 indexed citations
13.
Biswas, Pooja, Pongali B. Raghavendra, Bruno Lamontagne, et al.. (2017). Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent. Ophthalmic Genetics. 39(1). 73–79. 7 indexed citations
14.
Low‐Kam, Cécile, David Rhainds, Ken Sin Lo, et al.. (2016). Whole-genome sequencing in French Canadians from Quebec. Human Genetics. 135(11). 1213–1221. 13 indexed citations
15.
Denus, Simon de, Jean-Lucien Rouleau, Douglas L. Mann, et al.. (2016). A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. The Pharmacogenomics Journal. 17(2). 192–200. 13 indexed citations
16.
Tardif, Jean‐Claude, David Rhainds, Mathieu R. Brodeur, et al.. (2016). Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation. Circulation Cardiovascular Genetics. 9(4). 340–348. 53 indexed citations
17.
Shahabi, Payman, Yassamin Feroz Zada, Sylvie Provost, et al.. (2015). Impact of regular physical activity on weekly warfarin dose requirement. Journal of Thrombosis and Thrombolysis. 41(2). 328–335. 9 indexed citations
18.
Brown, Andrew, Yannick Renaud, Colin J.D. Ross, et al.. (2014). Development of a Broad-Based ADME Panel for Use in Pharmacogenomic Studies. Pharmacogenomics. 15(9). 1185–1195. 9 indexed citations
19.
Dubé, Marie‐Pierre, Amina Barhdadi, Andrew Brown, et al.. (2014). CKM and LILRB5 Are Associated With Serum Levels of Creatine Kinase. Circulation Cardiovascular Genetics. 7(6). 880–886. 32 indexed citations
20.
Barhdadi, Amina, Ian Mongrain, Valérie Normand, et al.. (2012). PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients. Pharmacogenetics and Genomics. 22(5). 336–343. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen M. Dumaual Breakdown of academic impact, for papers by Cristina Lucía Dávila-Fajardo Breakdown of academic impact, for papers by Guangyan Mu Breakdown of academic impact, for papers by Rhonda Porche-Sorbet Breakdown of academic impact, for papers by Jing‐Min Zheng Breakdown of academic impact, for papers by Michael W. Bolt Breakdown of academic impact, for papers by Mu-Peng Li Breakdown of academic impact, for papers by Tester F. Ashavaid Breakdown of academic impact, for papers by Liuh Ling Goh Breakdown of academic impact, for papers by Mohammed Tarif Hamza
Rankless by CCL
2026